×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| CORAL LABORATORIES LTD. | 255.09 | 61.44 | 229.86 | 17.20 | 278.0 | 10.2 |
| Trident Lifeline Limited | NA | NA | NA | NA | 276 | 32.1 |
| Nureca Limited | 279.4 | -28.01 | 264.63 | -2.80 | 271 |
Coral Laboratories Ltd., with Security Code 524506, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 25.6 | 24.7 | 11.4 | 13.5 | 23.1 | 18.0 | 28.8 | 31.6 | 32.2 | 22.9 |
| Expenses | 21.4 | 23.9 | 13.5 | 11.8 | 17.0 | 16.0 | 22.6 | 20.9 | 25.7 | 16.7 |
| Operating Profit | 4.3 | 0.8 | -2.1 | 1.7 | 6.2 | 2.1 | 6.2 | 10.7 | 6.5 | 6.3 |
| OPM % | 16.8% | 3.43% | -18.23% | 12.85% | 26.57% | 11.62% | 21.62% | 33.91% | 20.19% | 27.46% |
| Other Income | 2.2 | 1.5 | 1.2 | 1.3 | 1.8 | 1.4 | 2.0 | 1.6 | 2.5 | 2.5 |
| Interest | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 0.5 | 0.5 | 0.7 | 0.5 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| Profit before tax | 5.9 | 1.7 | -1.6 | 2.5 | 7.5 | 3.0 | 7.8 | 11.8 | 8.5 | 8.3 |
| Tax % | 17.2% | 51.7% | -45% | 25.9% | 20.2% | 27.6% | 25.3% | 25.2% | 25.2% | 26.1% |
| Net Profit | 4.9 | 0.9 | -0.9 | 1.8 | 6.0 | 2.2 | 5.8 | 8.8 | 6.4 | 6.1 |
| EPS in Rs | 13.7 | 2.4 | -2.5 | 5.16 | 16.81 | 6.04 | 16.2 | 24.64 | 17.86 | 17.2 |
| Metrics |
|---|
| Sales |
| Expenses |
| Operating Profit |
| OPM % |
| Other Income |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| Net Profit |
| EPS in Rs |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | -2% |
| 3 Years: | -5% |
| TTM: | 75% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 9% |
| 3 Years: | 6% |
| TTM: | 197% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 37% |
| 3 Years: | 42% |
| 1 Year: | 104% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|